Today: 3 March 2026
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest (ATMV) Rockets on AMC Robotics Merger Buzz – Key Facts & Forecast

AlphaVest Acquisition shareholders approved a merger with AMC Corporation on Sept 5, including $8 million in PIPE financing. Investors later allowed up to four one-month deadline extensions, each requiring a $55,000 deposit. About 1.513 million shares were redeemed, removing $18.2 million from the trust. ATMV shares spiked from $8.8 to $13 in pre-market trading on Oct 21 amid merger rumors.
21 October 2025
·····
Apple’s iPhone 17 BOOM: Sales Surge, Stock Soars Near $4T – What Analysts Say

Apple’s iPhone 17 BOOM: Sales Surge, Stock Soars Near $4T – What Analysts Say

Apple’s iPhone 17 lineup is selling 14% faster than last year’s model in the U.S. and China, with base model sales in China nearly doubling year-over-year, according to Counterpoint Research. Apple shares rose 4% to a record $263, lifting its market value to $3.9 trillion. Wall Street analysts raised price targets, though some warn expectations may be too high. Apple kept iPhone prices flat and launched new M5-chip devices without price hikes.
21 October 2025
····
Valletta Goes Green: MSC Cruises Powers Up Emission-Free Port Calls

Valletta Goes Green: MSC Cruises Powers Up Emission-Free Port Calls

MSC’s LNG-powered ships MSC World Europa and EXPLORA II used Valletta’s new shore-power system on consecutive days in October 2025, marking Malta’s first back-to-back connections and Explora Journeys’ first shore-power use in Europe. Since 2024, MSC ships have spent about 300 hours on shore power in Valletta, avoiding half a month’s diesel emissions while docked.
21 October 2025
·
Lockheed Martin Stock Soars on Earnings Beat – “We’re an arm of the U.S. government,” analyst quips

Lockheed Martin Stock Soars on Earnings Beat – “We’re an arm of the U.S. government,” analyst quips

Lockheed Martin reported Q3 sales of $18.61 billion and earnings of $6.95 per share, beating analyst estimates. The company raised its 2025 profit outlook and reported a record $179 billion backlog, including major new contracts for F-35 jets, CH-53K helicopters, and Patriot missiles. Shares rose about 2.6% in premarket trading to $518.97.
21 October 2025
···
GE Aerospace Stock Soars After Q3 Blowout: Raises 2025 Outlook Again

GE Aerospace Stock Soars After Q3 Blowout: Raises 2025 Outlook Again

GE Aerospace reported Q3 2025 GAAP revenue of $12.2 billion, up 24% year-over-year, and GAAP EPS of $2.04, beating analyst estimates. The company raised its full-year outlook, now guiding for 2025 adjusted EPS of $6.00–$6.20. Shares jumped 2.7% pre-market and are up about 78% year-to-date. Analysts remain mostly bullish but warn of high valuation and potential risks from tariffs or supply chain issues.
21 October 2025
···
Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa shares closed at $37.13, with analyst 12-month targets ranging from $42 to $65. The US and Australian governments agreed to fund a gallium plant at Alcoa’s Wagerup refinery, aiming for 100 metric tons per year. Alcoa warned US aluminum tariffs could cut Q3 results by $90 million. The company will hold an Investor Day at the NYSE on Oct. 30.
21 October 2025
·
Stratasys (SSYS) Stock Surges 14%: Why 3D Printing Shares Are Heating Up

Stratasys (SSYS) Stock Surges 14%: Why 3D Printing Shares Are Heating Up

Stratasys shares jumped 13.9% to $12.44 on Oct. 20, 2025, nearing a 52-week high amid a 44% year-to-date gain. Q2 revenue was flat at $138.1 million, with management cutting full-year guidance due to delayed orders. The company acquired Forward AM and Nexa3D assets this year, expanding its polymer 3D-printing portfolio. Analyst sentiment is mixed; Needham rates SSYS a Buy, while Weiss maintains a Sell.
21 October 2025
·
HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore (HTCR) Stock Soars on Dividend Surprise – Analysts Weigh In

HeartCore Enterprises (Nasdaq: HTCR) jumped about 40% in after-hours trading on Oct. 20 after announcing a one-time $0.13 per share dividend, yielding roughly 17.8%. The stock traded near $0.71 on Oct. 21, within a 52-week range of $0.39–$3.38. Q2 2025 results showed $4.7 million revenue and $1.1 million net income, reversing a prior loss. Record date for the dividend is Nov. 10, with payment set for Nov. 17.
21 October 2025
··
Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics Stock Soars on FDA Backing – Analysts Forecast ~70% Upside

Beam Therapeutics shares rose about 17% to $30 after the FDA granted RMAT and Orphan Drug designations to its lead gene-editing programs, BEAM-101 and BEAM-302. Early trial data showed BEAM-302 raised protective AAT levels and BEAM-101 produced durable increases in fetal hemoglobin. Wall Street’s average 12-month price target is $45–46, implying roughly 70–80% upside.
21 October 2025
··
DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo shares rose over 34% in after-hours trading Oct. 20, 2025, after announcing it will acquire telehealth provider SteadyMD using cash on hand. DocGo reported Q2 revenue of $80.4 million, down 51% year-over-year, and a net loss of $13.3 million. The company ended Q2 with $128.7 million in cash. A 2023 securities fraud lawsuit against DocGo remains active.
21 October 2025
·
SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

Spero shares closed at $2.29 on Oct. 20, 2025, up 3.6%, after reporting Phase 3 trial results showing oral tebipenem HBr matched IV imipenem in overall success (58.5% vs 60.2%) at IDWeek. The stock has surged over 120% year-to-date, trading between $0.51 and $3.22. GSK plans an FDA submission in Q4. Analyst 12-month targets average $5, but ratings remain mixed following a recent Zacks downgrade.
21 October 2025
···
Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside

Replimune shares jumped 99% to $8.94 on Oct. 20, 2025, after the FDA accepted its resubmitted BLA for lead cancer therapy RP1 plus nivolumab, setting a PDUFA decision date for April 10, 2026. New trial data showed a 44% response rate in acral melanoma. The stock’s rebound follows a 73% plunge in July after an FDA rejection. Market cap stands near $698 million.
21 October 2025
·
Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat (BYND) Stock Skyrockets 50% Amid Meme Mania – Turnaround or Dead Cat Bounce?

Beyond Meat shares surged 128% to $1.47 on Oct. 20 after a volatile week driven by a short squeeze and heavy trading volumes. The company completed a debt-for-equity swap on Oct. 15, cutting $900 million in debt but diluting shareholders as outstanding shares jumped from 76.7 million to 392 million. Sales and profits continue to fall, and analysts remain broadly bearish.
21 October 2025
·
Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix Stock Soars: Wall Street Targets $1,500 as Earnings Loom

Netflix shares closed at $1,238.56 on Oct. 20, up 3.3% and near all-time highs ahead of Q3 earnings. Analysts expect Q3 revenue of about $11.5 billion and EPS of $6.9–7.0, with focus shifting to advertising and margins. Netflix ended Q2 with 302 million paid subscribers and $2.3 billion in free cash flow. Wall Street remains bullish, with most analysts rating the stock a “Buy.”
21 October 2025
··
Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs Stock Rockets on Tariffs and Rare-Earth Push – But Caution Remains

Cleveland-Cliffs shares surged nearly 20% on Oct. 20, closing at $15.50 after Q3 results and rare-earth exploration plans. The company posted Q3 revenue of $4.73 billion and an adjusted loss of $0.45 per share, narrower than expected. Executives credited new U.S. steel tariffs for stronger demand and multi-year auto contracts. The stock is up about 42% year-to-date, far outpacing peers.
21 October 2025
·
1 … 68 69 70 71 72 … 140
Go toTop